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Abstract 
Purpose: To evaluate the effect of salvianolic acid B (Sal B) treatment on the motor function of spinal 
cord injury (SCI) rat. 
Methods: SCI rats were modelled by contusion, and then received 10 mg/kg Sal B, or 
methylprednisolone, or phosphate-buffered saline (PBS) intraperitoneally daily for 4 weeks, two hours 
after the trauma occurred. During the treatment, footprint analysis (FA), inclined plane test (IPT), Basso-
Beattie-Bresnahan (BBB) rating and Schnell Swim Test (SST) were used for estimating the recovery of 
motor function. At the same time, tissue edema was measured by wet-dry weighting, and the secretion 
of cytokines were indirectly quantitated by real time polymerase chain reaction (qPCR). 
Results: Primarily, Sal B group rats scored higher by FA, IPT and BBB rating. Further statistical 
analysis of comprehensive SST data from Student-t test indicates that Sal B can significantly ameliorate 
motor dysfunction after a 4-week treatment (p < 0.05) as well. Furthermore, Sal B decreased water 
content of the edema by 16.5 % during the first week, and sharply downregulated the transcription of 
interleukin 6 (IL-6) and tumor necrosis factor (TNF-α) 28- and 16-fold, respectively. 
Conclusion: The beneficial effect of motor function recovery was observed in SCI rats following 
intraperitoneal administration of Sal B. 
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SCI refers to injuries occurred to the spinal cord, 
it may be caused by primary injury due to 
trauma, and secondary injury due to the cascade 
of cellular and molecular events that after trauma 
[1,2]. Depending on where the spinal cord 
and nerve roots are damaged, the symptoms can 
vary widely, from pain to paralysis. In the United 
States, the incidence of SCI has been estimated 
to be about 40 cases per million population per 
year, and there are around 265,000 individuals 
living with SCIs at present with over 80% 
occurrence in males [3]. The prevalence of SCI is 
approximately 60,000 per year in China 
according to a recent report [4]. 
 
A traditional Chinese medicine, Salvia 
miltiorrhiza has been widely used in Asian 
countries for the treatment of cardiovascular and 
cerebrovascular diseases [5]. Currently, two 
major components extracted from the root of S. 
miltiorrhiza are Tanshinone IIA and salvianolic 
acid B (Sal B). The antioxidant Sal B has been 
shown to improve functional recovery in brain-
injured rats and provide neuroprotective effects 
in some experimental models of cerebral 
ischemia [6,7]. Recently, Deng et al. reported 
that Sal B improved motor function are partially 
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due to inhibition of increased TNF-α in the 
damaged spinal cord and exhibits 
neuroprotective effects [8,9].  
 
The present study was designed to determine 
whether Sal B could be reliably used for motor 
function repairing in SCI rats. With the contusion 
animal models, a series of tests were used for 
evaluating the capacity of Sal B treatment on SCI 
rats. By multiple-factor comparison, we 
confirmed the effectiveness of the Sal B 
treatment and shown how much extent it can be 
improved critically in terms of the motor function. 
Except for direct damage to the spinal cord from 
trauma, the secondary injuries are important for 
SCI treatment. Therefore, we also measured 
tissue edema and changes of cytokines in the 




Animals and drugs 
 
Healthy Sprague Dawley rats (40), weighing 220 
to 250 g (7 weeks old, male), were supplied by 
the Animal Center of Dalian Medical University, 
China. All the animals were housed at 25 °C in 
polycarbonate cages, 5 rats fed in one cage 
under controlled lighting (12 h light-dark cycle). 
Rats had free access to standard rodent water 
and chow throughout the experiment. Protocols 
were conducted in accordance with the latest 
Guide for the Care and Use of Laboratory 
Animals [10]. The standard chemical solution of 
Sal B was purchased from National Institute for 
the Control of Pharmaceutical and Biological 
Products (Beijing). PBS solution and 
methylprednisolone were purchased from Selleck 
(Shanghai, China). 
 
Establishment of SCI model and treatment 
 
Sprague Dawley rats (30) were subjected to 
acute spinal segment injury by contusion [11]. 
Briefly, the rats were intraperitoneally 
anesthetized using 0.4 % chloral hydrate (40 
mg/kg). The injury was introduced by impact 
force (20 g, 2.5 cm) to the segments T11 and 
T12 of spine, damage in which leading to 
paralysis of the leg muscles above and below the 
knee in human. The success of SCI model 
establishment was affirmed with the posterior 
limbs of retraction-like flutter and flaccid 
paralysis. The other 10 rats without SCI were 
housed in two cages as healthy control. For each 
group, animals were treated as folllowing: 10 rats 
were intraperitoneally administered with 10 
mg/kg Sal B, 10 rats with exactly the 
corresponding volume of PBS, and other 10 rats 
with 10 mg/kg methylprednisolone, respectively. 
All treatments began at 2 hours after injury, and 
lasted for 4 weeks with 24 hours interval.  
 
Test of tissue edema 
 
All forms of injury can cause spinal cord edema, 
further decreasing blood flow and oxygenation. 
Edema is one of the secondary events which 
might aggravate a primary injury and there are 
reasons to believe that compounds, like SalB, 
might be useful to ameliorate the adverse effect. 
As one of the most important traditional herbal 
medicines, it is widely used in clinic in China, 
Japan, and other countries for the treatment of 
coronary artery disease and other cardiovascular 
diseases. The wet and dry weight method was 
used to evaluate the extent of tissue edema [11].  
 
Evaluation of behavioral defect 
 
A variety of methods have been used to assess 
animal functional recovery after SCI. FA is one of 
the widely used non-invasive and quantitative 
method [12]. A series of at least six sequential 
steps were used to determine the mean values 
for measurement in a 5-point scoring system. 
The observation was conducted at the end of 
every week. IPT has been used routinely in 
models of SCI to clearly quantify the functional 
deficits due to major trauma to the central 
nervous system, which was modified from 
previously reported methods [13]. This technique 
requires the rat to maintain its position for 5 
seconds on a movable plane when the angle is 
adjusted by 1° inclination from 40° to a maximum 
of 55°. The maximum angle at which the rat can 
keep its position was recorded. The test was 
conducted once a week. BBB locomotor scale, 
the most widely used open field test has been 
accepted as a valid way to assess locomotor 
function after SCI in the rat [14]. All the rats were 
allowed to adapt for 5 min after they were moved 
out to an open field. The movement of each 
animal was recorded by a digital camera and 
subsequently scored by the evaluators, who 
were blind to the treatment of the injuries. A more 
comprehensive method, SST was proposed to 
measure motor function and recovery in spinal 
cord injured rats [15]. In this work, we measured: 
the velocity, forelimb strokes, tail movement, and 
the position of hindpaw. SST was conducted at 
the end of the treatment.  
 
Cytokine detection by qPCR 
 
Total RNA was extracted from injured tissue 
samples using the RNAeasy Kit (Qiagen, 
Germany) and 1 μg total RNA was used for 
cDNA synthesis with oligo dT and MMLV-RT 
purchased from Invitrogen. A total of 2 μL cDNA 
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was subjected to mRNA quantification using 
SYBR Green PCR Master Mix (Applied 
Biosystems, CA, USA). Briefly, quantitative PCR 
was performed using Roche LightCycler 480 for 
40 cycles at 95°C for 10s, specific annealing 
temperature for 5 s and annealing at 72 °C for 10 
s. Amplification specificity was checked using 
melting curve following the manufacturer's 
instructions. All experiments were performed 
twice in triplicate; all primers used were 
synthesized by Invitrogen (Shanghai, China) 
according to reference [16], sequence details are 




The results are expressed as mean ± standard 
deviation (SD). Statistical comparison between 
control and the drug-treated groups were 
performed using Student-t test for in vivo data, P 




This study was approved by the Animal Ethics 




Water content of edema tissue decreased 
after Sal B therapy 
 
Three rats from the SCI group were randomly 
chosen for tissue edema test after 1, 3, and 7 
days treatment. Water content in the spinal cord 
significantly decreased after 3 days in the model 
group treated with 10mg/kg Sal B (Table 2; P 
<0.05). Methylprednisolone can ameliorate tissue 
edema as well, though less effective than Sal B. 
After 7 days injection of Sal B, the edema tissue 
of SCI rats contained only 66.8 % water, which is 
about 10 % less than that for PBS-treated rats. 
 
Sal B ameliorates motor deficits evaluated by 
FA, IPT, BBB, SST 
 
Sal B-treated rats showed higher score after one 
week, and the scores increased over the 
following 3 weeks (Fig 1). This gait demonstrated 
a significant improvement in the Sal B-treated 
rats compared with the controls. Obviously, the 
improvement is much greater after 3 weeks 
injection.  
 
Table 2: Injured spinal cord water content (%) 
 
Days after SCI Group 
1 3 7 
PBS 83.3 80,1 76.5 
Sal B 75.6 71.2** 66.8** 
Methylprednisolone 78.4 75.7 72.9 
Rats were allowed to remove the injured spinal cord 
segments. These segments were immediately weighed and 
dried in an oven maintained at 100 oC for at least 72 h until 
the dry weight became constant. * *Significant 
 
Fig 1: Weekly FA of rats after treated with different 
chemicals. Values are scored as following standards: 
0, no constant dorsal stepping or hindlimb dragging; 1, 
at least three toes in three footprints; 2, rotation of the 
feet more than double; 3, no signs of toe dragging but 
foot rotation; 4, no signs of rotation but more than one 
visible heel print; 5, no visible heel prints. PBS, Sal B 
and Methylprednisolone are SCI rats treated with them 
respectively. Error bars indicate SEM; n=10 animals 




       Table 1: Primers used for amplification of cytokines and corresponding amplicons  
 
Gene name Primer Sequence cDNA position Accession no. 
FW AAGACAAGCCTGTGTTGCTGAAGG IL-1α 
RW TCCCAGAAGAAAATGAGGTCGGTC 
663–747 D00403 
FW CACCTCTCAAGCAGAGCACAG IL-1β 
RW GGGTTCCATGGTGAAGTCAAC 
793–871 M98820 
FW TCCTACCCCAACTTCCAATGCTC IL-6 
RW TTGGATGGTCTTGGTCCTTAGCC 
532–610 E02522 
FW AAATGGGCTCCCTCTCATCAGTTC TNF-α 
RW TCTGCTTGGTGGTTTGCTACGAC 
195–305 X66539 
FW AAGTCCCTCACCCTCCCAAAAG β-Actin 
RW AAGCAATGCTGTCACCTTCCC 
3474–3570 J00691 
FW = forward primer; RW = reverse primer; IL = interleukin; TNFα = tumor necrosis factor α; sequences are 
available at http://www.ncbi.nlm.nih.gov 
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Healthy rats can stay for 5 seconds on an 
inclined plane at an angle of 52°. However, the 
SCI rats treated with PBS as negative control 
after 1 week could only maintain their position at 
a much lower angle of, 42° exactly, while, the 
injuried rats that received 10 mg/kg Sal B 
demonstrated much stronger capacity to move 
on the plane at an angle as high as 49° (Fig 2). 
Even, following treatment (weeks 2 - 4) steadily 
enhanced this beneficial effect, but the 
improvement was clearly not as distinct as the 
first week.    
 
 
Fig 2: Motor disturbances of the rat hindlimbs after 
SCI, using an inclined plane test. Key: ◇ = PBS 
group; ■ = Sal B group; ▲ = methylprednisolone 
group. 
 
On the first day, all rats scored less than 4, 
indicating the contusion caused severe damage 
to motor function. And then, scores of all groups 
were increased greatly after treatment for 7 days 
(Fig 3). However, the trend becomes slower after 
two weeks for Sal B treated group even its score 
is still much higher than other groups.  
 
 
Fig 3: Temporal effect of different chemicals on motor 
disturbances after SCI by BBB rating. Key: ◇ = PBS 
group; ■ = Sal B group; ▲ = methylprednisolone 
group. 
 
Velocity and forelimb strokes, two objective 
measurable parameters, correlated with the 
extent of the lesions and allow the assessment of 
recovery after treatment. As demonstrated in Fig 
4A, the PBS-treated rats swam more slowly than 
Sal B-treated rats, meaning Sal B improved the 
velocity of SCI rats significantly than the other 
two counterparts. In Fig 4B, Sal B treatment 
decreased the stroke of forelimb more than 10 % 
compared to PBS group. Meantime, the position 
of the hindpaws of the Sal B-treated SCI rats was 
closer to the body axis relative to the PBS-
treated rats whose hindpaws deviated to a more 
lateral position (Fig 4D). However, there was little 
influence of these treatments on the movement 
of tails when  swimming of the rats was observed 
in this test (Fig 4C).  
 
 
We utilized SYBR Green qPCR protocol to assay 
pro-inflammatory cytokines (IL-1α, IL-1β and IL-
6, TNF-α), normalized with the housekeeping 
genes β-actin. Based on Figure 5, the 
transcription of IL-1 is basically resistant to the 
treatment. More specifically, IL-1α seems to have 
little contribution to SCI and its treatment, even 
IL-1β transcription was upregulated about 6 
times. The most striking results came from 
comparisons of IL-6 and TNF-α. Obviously, the 
abundance of IL-6 and TNF-α is much higher in 
SCI rats. However, Sal B treatment can 
significantly downregulate the transcription of IL-
6 and TNF-α, about 28-fold and 16-fold 
respectively. The sharp fluctuations of IL-6 and 
TNF-α may play important role in the recovery of 




In the experimental treatment of SCI, the 
behavioral test depends on the injury model. 
Moderate or mild injuries can be simulated using 
devices such as weight drop, which will lead to a 
compression-type injury to the spinal cord [17]. 
Thus the animals tend to show limitation in the 
substantial use of their hind limbs due to the 
survival of axonal pathways. 
  
Many tests are sensitive to this region of 
functionality including IPT and FA among others 
[18]. IPT has added utility since it does not 
require an extensive training period or motivation 
tactics and is simple, straightforward. In this 
paper, we used the contusion method for SCI 
model establishment as its easy operation and 
this is quite similar to SCI occurs naturally in 
human. FA and IPT indicate daily 
intraperitoneal injection of 10mg/kg Sal B can 
significantly repair the motor dysfunction, and,  
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Fig 4: SST of motor function recovery after treatment in contusion SCI rats. (A) Swimming velocity. The mean of 
three runs obtained from normal rats was taken as 100 % (30 frames). (B) Forelimb strokes. A maximum of 2 
forelimb strokes per 60 cm swimming distance was considered the normal value, representing 100 %. One more 
forelimb stroke decreases the performance by 2 %. (C) Tail movement. A score of 4 represents normal tail 
movements in unlesioned rats, while a completely paretic tail with very rare twitching was given a score of 1, and 
a total absence of movement scores 0. (D) Hindpaw position. The normal swimming position was assigned 4, 











Figure 5: qPCR analysis of cytokines transcription 
profile of the injured spinal cord after treatment for 1 
day. The data represent mean values (n = 3) and 2 
independent experiments (2 rats for each group). Ct is 
cycle of threshold, which indicated the abundance of 
cDNA template transcripted from mRNA. Bars with 
vertical lines = PBS group; bars with horizontal lines = 
Sal B group; blank bars = methylprednisolone group 
 
most importantly, 4-week treatment can nearly 
restore the motor function to normal level.  
 
However, these two tests are too simple to 
illustrate the thoroughly measurable 
effectiveness on SCI treatment. Therefore, BBB 
locomotor rating which is almost exclusively used 
in this situation was used for evaluation. Indeed, 
the BBB scale is the most popular method for 
tracking functional outcome in moderate or mild 
injury models as well [19]. In general, using this 
method produces consistent results. That is Sal 
B treatment improves motor function, and this 
beneficial effect is evidently stronger in the 
former two weeks. When considering more 
parameters, the effectiveness of Sal B is limited 
within the cure-period (4 weeks), while BBB 
rating cannot produce a correct assessment of 
forelimb-hind limb coordination.  
 
Some researchers successfully used the 
regularity index (RI) to determinate the functional 
recovery after SCI [20], the calculation of RI is 
much complicated as it relating to a few factors. 
Rats can swim naturally, so swimming can be 
used to obtain objective results in the analysis of 
motor function after various types of spinal cord 
lesions. For mild to moderate bilateral dorsal 
lesions, the assessment of velocity and forelimb 
strokes can be sufficient to obtain reliable results 
which correlate with the extent of the lesion or 
with the degree of recovery after treatment [21]. 
Swimming also allowed the novel observation in 
rats of muscle spasms in spinal cord injured rats 
during the course of recovery [22]. 
 
After SCI, one common phenomenon is tissue 
edema. It seems Sal B eliminates the water 
content effectively after 3 days. The same result 
was also obtained in other study [9]. A complex 
cascade of pathophysiological processes rapidly 
damage the nervous tissue after initial tramua. 
Inflammation is one of the major secondary 
pathologies following SCI [23], and severe 
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inflammatory responses in the injured spinal cord 
destroy neurons, leading to exacerbate 
neurodegeneration [24]. Inflammation contributes 
to secondary damage partly through over-release 
of cytokines, such as TNF-α, which enhance 
permeability of endothelial cells and facilitate 
trans-endothelial migration of activated 
leukocytes to the injured area [25,26]. Virtually all 
nucleated cells, but especially endo/epithelial 
cells and resident macrophages are potent 
producers of IL-1, IL-6, and TNF-α [27]. Some 
cytokines (such as IL-6) can increase up to 1000-
fold during trauma or infection. The expression of 
IL-6 is sharply increased in the acute stages after 
spinal cord injury and it may serve as a factor 
strongly inducing the differentiation of neural 
stem cells into astrocytes [28]. In our experiment, 
the lower IL-6 concentration is related to less SCI 
as well. Sal B may suppressed the secondary 
injury by inhibiting the transcription of IL-6 and 
TNF-α, as proposed by other reaserch [9]. 
 
Methylprednisolone was the first neuroprotective 
drug to be discovered, and is the current 
standard in treatment although its efficacy has 
been called into question [29]. We used this 
chemical as a positive control, to compare the 
effectiveness of Sal B. Other studies reported 
various drugs for the experimental cure of SCI 
[30,31]; however, we believe that Sal B is a good 
competitor considering its multiple usage and the 




Sal B is a promising promoter of rat motor 
dyfunction recovery after estimation by footprint 
annlysis, inclined plane test, BBB rating and SST 
analysis. At the same time, Sal B treatment can 
ameliorate tissue edema and downregulate the 
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